How should an adult presenting to the emergency department with a random plasma glucose of 150 mg/dL or higher be managed?

Emergency Department Management of Hyperglycemia ≥150 mg/dL

For adults presenting to the ED with random plasma glucose ≥150 mg/dL who are stable and without hyperglycemic crisis, do not routinely initiate insulin treatment in the ED—instead, inform the patient of the elevated glucose, establish or confirm a diabetes diagnosis if glucose ≥200 mg/dL with symptoms, and arrange urgent outpatient follow-up within 1-4 weeks.

Initial Assessment and Diagnosis

When a patient presents with glucose ≥150 mg/dL, immediately determine if this represents:

• Hyperglycemic crisis (DKA or HHS): Check for altered mental status, severe dehydration, pH <7.3, bicarbonate <15 mEq/L, or significant ketosis 1, 2
• Known diabetes with uncontrolled hyperglycemia
• New-onset diabetes (random glucose ≥200 mg/dL with hyperglycemic symptoms) 3, 4
• Stress hyperglycemia (elevated glucose with HbA1c <6.5%) 5

Key point: If the patient has no altered mental status, adequate hydration, and no evidence of DKA/HHS, this is not a hyperglycemic emergency requiring aggressive ED intervention.

When NOT to Treat Aggressively in the ED

The evidence strongly suggests against routine IV insulin administration for non-emergent hyperglycemia in the ED:

• IV insulin for isolated hyperglycemia (without crisis) provides only modest glucose reduction (37 mg/dL for >5 units) with no improvement in ED length of stay 6
• Risk of hypokalemia occurs in 7.9% of patients receiving IV insulin 6
• The critical care literature establishes treatment thresholds at ≥180 mg/dL for hospitalized patients, not 150 mg/dL 7, 8, 9

Appropriate ED Management Algorithm

For glucose 150-179 mg/dL:

• Document the finding
• Inform the patient of the elevation 10
• Arrange outpatient follow-up within 2-4 weeks
• No ED treatment required

For glucose 180-199 mg/dL:

• Consider checking HbA1c if not done in past 3 months 9
• Inform patient and provide diabetes education materials
• Arrange follow-up within 1-2 weeks
• Consider starting metformin if patient has established diabetes and is not currently on therapy 4

For glucose ≥200 mg/dL with hyperglycemic symptoms:

• Establish new diabetes diagnosis per ADA criteria 3, 4
• Check HbA1c to assess chronic glycemic control 9
• Initiate treatment based on severity:
  • Glucose 200-300 mg/dL: Start metformin 500-850 mg daily or defer to outpatient management within 1 week 4
  • Glucose >300 mg/dL: Consider starting long-acting insulin (e.g., glargine 10 units daily) OR metformin with close follow-up in 12-72 hours 11
• Provide survival skills diabetes education 9, 11

For glucose >300 mg/dL with ketosis or clinical instability:

• Admit for IV insulin infusion 1, 2
• Follow DKA/HHS protocols even if pH >7.3

Critical Pitfalls to Avoid

Do not use IV insulin for isolated hyperglycemia in stable ED patients. The older DKA guidelines mention supplemental subcutaneous insulin "in 5-unit increments for every 50 mg/dL increase above 150 mg/dL" 1, 2, but this recommendation applies specifically to hospitalized patients already on IV insulin who are NPO and transitioning off the infusion—not to ED patients being discharged.

The major missed opportunity: Studies show that 42% of ED patients with glucose ≥150 mg/dL are discharged, but only 2.2% are informed of the elevation and referred for follow-up 10. This represents a critical failure in diabetes screening and prevention.

Discharge Planning

For patients being discharged with elevated glucose:

• Document the glucose elevation prominently in discharge instructions
• Explicitly inform the patient of the finding and its significance 12, 10
• Arrange definitive follow-up within 1-4 weeks depending on glucose level
• Provide contact information for primary care or endocrinology
• Consider initiating metformin or basal insulin for glucose >200 mg/dL if appropriate 4, 11
• Give written diabetes education materials 9

Special Considerations

Stress hyperglycemia: If HbA1c <6.5% with elevated random glucose, this likely represents stress response. No immediate treatment needed, but 60% will develop diabetes within one year—arrange glucose monitoring at 1 month and annually 5.

Perioperative patients: For elective surgery candidates with hyperglycemia, preadmission treatment improves outcomes—refer to endocrinology before procedure 9.

The 150 mg/dL threshold in your question does not represent a treatment trigger in the ED setting. Current guidelines establish 180 mg/dL as the threshold for initiating insulin therapy in hospitalized patients 7, 8, 9, and even this applies to admitted patients, not ED discharges.